Skip Navigation or Skip to Content
Blog Author
Tenthpin

California’s Low-Cost Insulin Is Symptom Of Lifesaving Innovations To Come

Featured image: California’s Low-Cost Insulin Is Symptom Of Lifesaving Innovations To Come

Susan Galer has published on Forbes covering the SAP Life Sciences event, featuring remarks from Michael Schmidt’s excellent trends session.

Read the full article here

screenshot_2022-07-25_at_11.52.3

screenshot_2022-07-25_at_11.53.0

screenshot_2022-07-25_at_11.53.2

screenshot_2022-07-25_at_11.53.4

screenshot_2022-07-25_at_11.54.1

Share This Blog

Related insights

The Life Sciences sector is undergoing a major shift, which is having a profound impact on Contract Development and Manufacturing...

Purpose-built Product Lifecycle Management (PLM) solutions accelerate innovation while ensuring regulatory compliance and...

Want to discover how leading CDMOs have transformed their businesses with SAP? Real-world success stories with proven best...

We are a globally leading business and technology boutique consultancy for the Life Sciences industry. Our clients are leading companies from pharma, biotech, med tech, healthcare & animal health.

© 2025 Tenthpin AG | Illustrations by: www.till-lauer.ch